Description
6 1/2 X 9 7/16 in I. CENTRAL NERVOUS SYSTEM DISEASES (A.J. Robichaud). 1 . Novel approaches for the treatment of schizophrenia (B.N. Rogers, C.J . Schmidt). 2. Recent strategies for the development o f new antidepressant drugs (D.A. Evrard). 3. Neuroprot ective agents for the treatment of ischemic and hemorrhagic stroke (S.N. Haydar, W.D. Hirst). 4. Novel sodium channel blocker s for the treatment of neuropathic pain (B. Marron). II. CARDIOVASCULAR AND METABOLIC DISEASES (A. Stamford). 5. Centrally acting anti-obesity agents (D. Hepworth et al.). 6. Nuclear Hormone Receptor Modulat ors for the Treatment of Diabetes and Dyslipidemia (P.T. Meinke et a l.). 7. 11 -Hydroxysteroid Dehydrogenase T ype 1 Inhibitors (C.D. Boyle et al.). 8. Glu cokinase Activators for the Treatment of Type 2 Diabetes (P.S. Humphries , T.O. Johnson). 9. Renin Inhibitors (C.M. Tice). 10. Antiarryhthmic Agents (M.J. Suto, D.S. Krafte).
